Registry of Lobbyists
Total Number of Communication Reports: 0
Monthly communication reports in the last 6 months: 0
| Subject matters | Details | Categories |
|---|---|---|
|
Health, Regional Development, Research and Development, Science and Technology
|
Identify opportunities and seek funding to expand the Canadian Clinical Trial Network, which conducts research into finding a cure for Type 1 Diabetes (T1D).
|
Grant, Contribution or Other Financial Benefit
|
|
Health, Research and Development, Science and Technology
|
Monitor developments regarding Health Canada's process for approving new technology assisted devices
|
Policies or Program
|
|
Health, Research and Development, Science and Technology
|
Monitor developments regarding the application approval process for the Disability Tax Credit and the Registered Disability Pension Plan
|
Policies or Program
|
Address:
235 Yorkland Blvd., Suite 600
Toronto, ON M2J 4Y7
Canada
Telephone number:
647-789-2000
Ext.
2015
Dave Prowten, President and Chief Executive Officer
Juvenile Diabetes Research Foundation / Fondation de la recherche sur le diabète juvénile is not a subsidiary of any other parent companies.
Juvenile Diabetes Research Foundation / Fondation de la recherche sur le diabète juvénile is not a coalition.
The activities of Juvenile Diabetes Research Foundation / Fondation de la recherche sur le diabète juvénile are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Juvenile Diabetes Research Foundation / Fondation de la recherche sur le diabète juvénile does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Heena Kapoor | No public offices held
Firm: Temple Scott Associates Inc.